WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 13D and 13G filings for Ligand Pharmaceuticals Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 1:53 pm Sale |
2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 141,128 0.800% |
-2,103,619 (-93.71%) |
Filing |
| 2022-02-09 6:54 pm Purchase |
2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2,244,747 8.400% |
193,631 (+9.44%) |
Filing |
| 2021-05-07 3:55 pm Sale |
2021-04-30 | 13G | Ligand Pharmaceuticals Incorporated LGND |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2,051,115 7.700% |
-1,220,680 (-37.31%) |
Filing |
| 2021-02-11 2:54 pm Purchase |
2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3,271,795 12.700% |
233,511 (+7.69%) |
Filing |
| 2020-10-08 09:17 am Purchase |
2020-09-30 | 13G | Ligand Pharmaceuticals Incorporated LGND |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3,038,285 11.800% |
767,074 (+33.77%) |
Filing |